Skip to main content
IDXX logo

IDEXX Laboratories, Inc.

IDXXNASDAQHealthcareDiagnostics & Research

$560.36Today:- (-)1Y −13.88%

As of Oct 16, 2026 close

Market cap
$43.40B
P/E (TTM)
38.08
Forward P/E
33.29
Dividend yield
-
52-week range
$500.61$769.98
Volume (live)
-
Avg. volume (3M)
521.15K

IDEXX Laboratories (IDXX) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), IDEXX Laboratories had a P/E ratio of 50.99 (up from 38.13), return on equity of 66.2% (up from 57.7%), debt-to-equity of 0.61 (down from 0.62) and a current ratio of 1.23 (down from 1.31). A current ratio of 1.23 means current assets exceed current liabilities.

IDEXX Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio50.9938.1354.5549.7574.9673.29
Forward P/E48.0335.3551.9244.2573.7776.45
P/S Ratio12.558.6912.5910.0317.3615.75
P/B Ratio33.6521.2231.0555.5080.9267.38
Price/Tangible Book49.9531.3944.58226.34241.06126.83
Price/FCF51.1041.9059.6485.7287.7978.80
Price/OCF45.7136.4450.8562.2273.9065.79
PEG Ratio3.242.552.741.912.873.70
Enterprise Value Ratios
EV/Revenue12.768.8612.8110.4517.6216.05
EV/EBITDA36.4926.1738.7034.8254.6554.97
EV/EBIT40.3929.0342.7539.1660.7862.57
EV/FCF51.9642.7560.6989.2989.0880.31
Profitability & Returns
Return on Equity (ROE)66.20%57.66%80.74%104.58%112.62%143.63%
Return on Assets (ROA)25.59%22.70%22.83%21.67%24.62%21.04%
Return on Invested Capital (ROIC)46.35%43.35%42.99%40.07%54.38%30.10%
Return on Capital Employed (ROCE)61.80%53.50%47.50%59.50%55.70%40.60%
Leverage & Solvency Ratios
Debt/Equity0.610.620.722.421.491.58
Debt/EBITDA0.630.730.861.410.971.23
Debt/FCF0.921.221.383.731.621.85
Liquidity Ratios
Current Ratio1.231.311.570.891.251.82
Quick Ratio0.760.801.030.490.751.30
Efficiency Ratios
Asset Turnover1.291.191.221.301.361.31
Inventory Turnover4.333.983.934.285.545.61
Yield & Distribution Ratios
Earnings Yield1.96%2.62%1.83%2.01%1.33%1.36%
FCF Yield1.96%2.39%1.68%1.17%1.14%1.27%
Buyback Yield2.67%0.87%0.74%2.28%0.17%0.94%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About IDEXX Laboratories Financial Ratios

What is IDEXX Laboratories's P/E ratio?

IDEXX Laboratories's P/E ratio was 50.99 for fiscal 2025 (period ended Dec 31, 2025). It was 38.13 a year earlier.

What is IDEXX Laboratories's return on equity?

IDEXX Laboratories's return on equity (ROE) was 66.2% for fiscal 2025 (period ended Dec 31, 2025). It was 57.7% a year earlier.

What is IDEXX Laboratories's debt-to-equity ratio?

IDEXX Laboratories's debt-to-equity ratio was 0.61 for fiscal 2025 (period ended Dec 31, 2025). It was 0.62 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition